Related Experiment Videos
Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging
S Achilefu1, R B Dorshow, J E Bugaj
1Discovery Research, Mallinckrodt Inc., St. Louis, Missouri 63042, USA. Samuel.achilefu@mkg.com
Rationale And Objectives:
To evaluate the efficacy of a novel tumor receptor-specific small-peptide-near-infrared dye conjugate for tumor detection by optical imaging.
Methods:
A novel, near-infrared dye-peptide conjugate was synthesized and evaluated for tumor-targeting efficacy in a well-characterized rat tumor model (CA20948) known to express receptors for the chosen peptide. A simple continuous-wave optical imaging system, consisting of a near-infrared laser diode, a cooled CCD camera, and an interference filter, was used in this study.
Results:
Tumor retention of two non-tumor-specific dyes, indocyanine green and its derivatized analogue, bis-propanoic acid cyanine dye (cypate), was negligible. In contrast, the receptor-specific peptide-cypate conjugate (cytate) was retained in the CA20948 tumor, with an excellent tumor-tonormal-tissue ratio in the six rats examined.
Conclusions:
Optical detection of tumors with a receptor-targeted fluorescent contrast agent has been demonstrated. This result represents a new direction in cancer diagnosis and patient management.
Insights
A novel fluorescent dye linked to a peptide effectively targets and highlights tumors in optical imaging. This receptor-specific contrast agent shows promise for improved cancer diagnosis and patient management.
Area of Science:
- Biomedical Optics
- Molecular Imaging
- Cancer Diagnostics
Background:
- Optical imaging offers a non-invasive method for tumor detection.
- Targeted contrast agents are crucial for enhancing image sensitivity and specificity.
- Developing receptor-specific agents improves tumor visualization.
Purpose of the Study:
- To assess the efficacy of a novel small-peptide-near-infrared dye conjugate.
- To evaluate its capability for tumor detection using optical imaging.
- To determine if receptor specificity enhances tumor targeting.
Main Methods:
- Synthesis of a near-infrared dye-peptide conjugate (cytate).
- Evaluation in a rat tumor model (CA20948) expressing specific peptide receptors.
- Utilized a continuous-wave optical imaging system with NIR laser and CCD camera.
Main Results:
- Non-specific dyes (ICG, cypate) showed negligible tumor retention.
- The receptor-specific conjugate (cytate) demonstrated significant retention in the target tumor.
- Achieved an excellent tumor-to-normal-tissue ratio in optical imaging.
Conclusions:
- Demonstrated successful optical tumor detection using a receptor-targeted fluorescent contrast agent.
- This approach represents a novel strategy for cancer diagnosis.
- Highlights potential for improved patient management through enhanced imaging.